These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
359 related items for PubMed ID: 15992629
1. Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction. van Domburg RT, Sonnenschein K, Nieuwlaat R, Kamp O, Storm CJ, Bax JJ, Simoons ML. J Am Coll Cardiol; 2005 Jul 05; 46(1):15-20. PubMed ID: 15992629 [Abstract] [Full Text] [Related]
2. Three life years gained after reperfusion therapy in acute myocardial infarction: 25-30 years after a randomized controlled trial. Domburg RT, Hendriks JM, Kamp O, Smits P, Melle Mv, Schenkeveld L, Bax JJ, Simoons ML. Eur J Prev Cardiol; 2012 Dec 05; 19(6):1316-23. PubMed ID: 22013152 [Abstract] [Full Text] [Related]
3. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy. Dryja T, Kornacewicz-Jach Z, Goracy J, Przybycień K, Jodko L, Skowronek A, Kurowski M, Zinka E. Kardiol Pol; 2006 Jun 05; 64(6):591-9; discussion 600-1. PubMed ID: 16810577 [Abstract] [Full Text] [Related]
4. Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Brodie BR, Stuckey TD, Muncy DB, Hansen CJ, Wall TC, Pulsipher M, Gupta N. Am Heart J; 2003 Apr 05; 145(4):708-15. PubMed ID: 12679769 [Abstract] [Full Text] [Related]
5. [Percutaneous coronary revascularization in patients over eighty: acute and long-term results]. Lettieri C, Buffoli F, Romano M, Aroldi M, Baccaglioni N, Tomasi L, Rosiello R, Agostini F, Kuwornu H, Pepi P, Izzo A, Zanini R. Ital Heart J Suppl; 2005 Sep 05; 6(9):588-98. PubMed ID: 16281718 [Abstract] [Full Text] [Related]
6. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, Stone GW. Eur Heart J; 2007 Jul 05; 28(14):1709-16. PubMed ID: 17556348 [Abstract] [Full Text] [Related]
7. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study. De Luca L, Bolognese L, Casella G, Savonitto S, Gonzini L, Di Chiara A, De Servi S, Notaristefano S, Valagussa L, Maggioni AP, Chiarella F, BLITZ Investigators. J Cardiovasc Med (Hagerstown); 2008 Oct 05; 9(10):1045-51. PubMed ID: 18799968 [Abstract] [Full Text] [Related]
8. The role of reperfusion therapy in paced patients with acute myocardial infarction. Rathore SS, Gersh BJ, Weinfurt KP, Oetgen WJ, Schulman KA, Solomon AJ. Am Heart J; 2001 Sep 05; 142(3):516-9. PubMed ID: 11526367 [Abstract] [Full Text] [Related]
9. Gender differences in the outcome of cardiac interventions. Tillmanns H, Waas W, Voss R, Grempels E, Hölschermann H, Haberbosch W, Waldecker B. Herz; 2005 Aug 05; 30(5):375-89. PubMed ID: 16132240 [Abstract] [Full Text] [Related]
10. [Long-term prognosis after reperfusion therapy with emergency coronary angioplasty for acute myocardial infarction]. Dote K, Sato H, Tateishi H, Uchida T, Ishihara M, Yoshimura M, Ohkura Y, Watanabe M, Muraoka Y. J Cardiol; 1991 Aug 05; 21(3):613-23. PubMed ID: 1843512 [Abstract] [Full Text] [Related]
11. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Shen J, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF. Coron Artery Dis; 2008 Jun 05; 19(4):271-7. PubMed ID: 18480672 [Abstract] [Full Text] [Related]
12. Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial. Brouwer MA, Kievit PC, Dieker HJ, Veen G, Karreman AJ, Verheugt FW. Am Heart J; 2008 Jun 05; 155(6):1039-46. PubMed ID: 18513517 [Abstract] [Full Text] [Related]
13. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I. Kaul P, Armstrong PW, Chang WC, Naylor CD, Granger CB, Lee KL, Peterson ED, Califf RM, Topol EJ, Mark DB. Circulation; 2004 Sep 28; 110(13):1754-60. PubMed ID: 15381645 [Abstract] [Full Text] [Related]
14. Clinical characteristics, hospital morbidity and mortality, and up to 1-year follow-up events of acute myocardial infarction patients: the first report from Iran. Ghadimi H, Bishehsari F, Allameh F, Bozorgi AH, Sodagari N, Karami N, Yaghoubi M, Emami S, Ghadimi F, Haerizadeh BF, Sanati A. Coron Artery Dis; 2006 Nov 28; 17(7):585-91. PubMed ID: 17047441 [Abstract] [Full Text] [Related]